A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells

FASEB Journal

Volumn 27, Issue 8, 2013, Pages 3272-3283

  Sioud, Mouldy ^a   Skorstad, Gjertrud ^a   Mobergslien, Anne ^a   Sæbøe Larssen, Stein ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Cancer vaccines; Cross presentation; Phage display; SiRNA

Indexed keywords

ANTIGEN; CD45RO ANTIGEN; CYTOMEGALOVIRUS ANTIGEN PP65; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEIC ACID; NW PEPTIDE; SMALL INTERFERING RNA; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; MATRIX PROTEIN; OLIGOPEPTIDE; PHOSPHOPROTEIN; PROTEIN BINDING;

ANTIGENICITY; ARTICLE; BIOPANNING; CELL EXPANSION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DENDRITIC CELL; DRUG BINDING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; EX VIVO STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MONOCYTE; PEPTIDE LIBRARY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TARGETING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS STRAIN; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; BINDING COMPETITION; CELL CULTURE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS; BINDING, COMPETITIVE; CARRIER PROTEINS; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MICROSCOPY, FLUORESCENCE; MONOCYTES; NUCLEIC ACIDS; OLIGOPEPTIDES; PHOSPHOPROTEINS; PROTEIN BINDING; RNA, SMALL INTERFERING; T-LYMPHOCYTES; VIRAL MATRIX PROTEINS;

EID: 84881127984     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-224758     Document Type: Article

References (44)

1. Banchereau, J., and Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252
2. Palucka, K., Banchereau, J., and Mellman, I. (2010) Designing vaccines based on biology of human dendritic cell subsets. Immunity 33, 464-478
3. Flatekval, G. F., and Sioud, M. (2009) Modulation of dendritic cell maturation and function with mono-and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase. Immunology 128, e837-e848
4. Tacken, P. J., and Figdor, C. G. (2011) Targeted antigen delivery and activation of dendritic cells in vivo. Steps towards cost effective vaccines. Sem. Immunol. 23, 12-20
5. Johnson, T. S., Mahnke, K., Storn, V., Schonfeld, K., Ring, S., Nettelbeck, D. M., Haisma, H. J., Le Gall, F., Kontermann, R. E., and Enk, A. H. (2008) Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule. Clin. Cancer Res. 14, 8169-8177
6. Wei, H., Wang, S., Zhang, D., Hou, S., Qian, W., Li, B., Guo, H., Kou, G., He, J., Wang, H., and Guo, Y. (2009) Targeted delivery of tumor antigens to activate dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Clin. Cancer Res. 15, 4612-4621
7. Kretz-Rommel, A., Qin, F., Dakappagari, N., Torensma, R., Faas, S., Wu, D., and Bowdish, K. S. (2007) In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models. J. Immunother. 30, 715-726
8. Hangalapura, B. N., Oosterhoff, D., de Groot, J., Boon, L., Tuting, T., van den Eertwegh, A. J., Gerritsen, W. R., van Beusechem, V. W., Pereboev, A., Curiel, D. T., Scheper, R. J., and de Gruijl, T. D. (2011) Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine. Cancer Res. 71, 5827-5837
9. Birkholz, K., Schwenkert, M., Keller, C., Gross, S., Fey, G., Schuler-Thurner, B., Schuler, G., Schaft, N., and Dörrie, J. (2010) Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. Blood 116, 2277-2285
10. Serre, K., Machy, P., Grivel, J. C., Jolly, G., Brun, N., Barbet, J., and Leserman, L. (1998) Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells. J. Immunol. 161, 6059-6067
11. He, L. Z., Crocker, A., Lee, J., Mendoza-Ramirez, J., Wang, X. T., Vitale, L. A., O'Neill, T., Petromilli, C., Zhang, H. F., Lopez, J., Rohrer, D., Keler, T., and Clynes, R. (2007) Antigenic targeting of the human mannose receptor induces tumor immunity. J. Immunol. 178, 6259-6267
12. Tacken, P. J., de Vries, J. M., Gijzen, K., Joosten, B., Wu, D., Rother, R. P., Faas, S. J., Punt, C. J. A., Torensma, R., Adema, G. J., and Figdor, C. G (2005) Effective induction of naïve and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 106, 1278-1285
13. Kurts, C., Robinson, B. W., and Knolle, P. A. (2010) Crosspriming in health and disease. Nat. Rev. Immunol. 2010, 403-414
14. Shadidi, M., and Sioud, M. (2003) Selective targeting of cancer cells using synthetic peptides. Drug Resist. Update 6, 363-371
15. Smith, G. P., and Scott, J. K. (1993) Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217, 228-257
16. Laakkonen, P., Porkka, K., Hoffman, J. A., and Ruoslahti, E. (2002) A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 8, 751-755
17. Costantini, T. W., Eliceiri, B. P., Putnan, J. G., Bansal, V., Baird, A., and Coimbra, R. (2012) Intravenous phage display identifies peptide sequences that target the burn-injured intestine. Peptides 38, 94-99
18. Dybwad, A., Øystein, F., Kjeldsen-Kragh, J., Natvig, J. B., and Sioud, M. (1993) Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library. Eur. J. Immunol. 23, 3189-3193
19. Hansen, M. H., Østenstad, B., and Sioud, M. (2001) Antigenspecific IgG antibodies in stage IV long-time survival breast cancer patients. Mol. Med. 7, 230-239
20. Shadidi, M., and Sioud, M. (2003) Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells. FASEB J. 17, 256-258
21. Wang, X. F., Birringer, M., Dong, L. F., Veprek, P., Low, P., Swettenham, E., Stantic, M., Yuan, L. H., Zobalova, R., Wu, K., Ledvina, M., Ralph, S. J., and Neuzil, J. (2007) A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression. Cancer Res. 67, 3337-3344
22. Luo, H., Yang, J., Jin, H., Huang, C., Fu, J., Yang, F., Gong, H., Zeng, S., Luo, Q., and Zhang, Z. (2011) Tetrameric far-red fluorescent protein as a scaffold to assemble an octavalent peptide nanoprobe for enhanced tumor targeting and intracellular uptake in vivo. FASEB J. 25, 1-9
23. Sioud, M., and Mobergslien, A. (2012) Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides. Bioconjugate. Chem. 23, 1040-1049
24. Wills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weeks, M. P., Plachter, B., and Sissons, J. G. P. (1996) The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70, 7569-7579
25. Li Pira, G., Bottone, L., Ivalidi, F., Pelizzoli, R., Del Galdo, F., Lozzi, L., Bracci, L., Loregian, A., Palù, G., De Palma, R., Einsele, H., and Manca, F. (2004) Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution. Int. Immunol. 16, 635-642
26. Trivedi, D., Williams, R. Y., O'Reilly, R. J., and Koehne, G. (2005) Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy. Blood 105, 2793-2801
27. Jedema, I., van de Meent, M., Pots, J., Kester, M. G., van der Beek, M. T., and Falkenburg, J. H. (2011) Successful generation of primary virus-specific and anti-tumor T-cell responses from the naive donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells and regulatory T cells. Haematologica 96, 1204-1212
28. FalciaBooth, N. J., McQuaid, A. J., Sobande, T., Kissane, S., Agius, E., Jackson, S. E., Salmon, M., Falciani, F., Yong, K., Rustin, M. H., Akbar, A. N., and Vukmanovic-Stejic, M. (2010) Different proliferative potential and migratory characteristics of human CD4-regulatory T cells that express either CD45RA or CD45RO. J. Immunol. 184, 4317-4326
29. Fry, T. J., and Mackall, C. L. (2005) The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174, 6571-6576
30. Auffray, C., Sieweke, M. H., and Geissmann, F. (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692
31. Whitehead, K. A., Langer, R., and Anderson, D. G (2009) Knocking down barriers: advances in siRNA delivery. Nature Rev. Drug Discov 8,129-138
32. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498
33. Tacken, P. J., de Vries, I. J. M., Torensma, R., and Figdor, C. G. (2007) Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7, 790-802
34. Bozzacco, L., Trumpfheller, C., Siegal, F. P., Mehandru, S., Markowitz, M., Carrington, M., Nussenzweig, M. C., Piperno, A. G., and Steinman, R. M. (2007) DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8-T cells in a spectrum of human MHC I haplotypes. Proc. Natl. Acad. Sci. U. S. A. 104, 1289-1294
35. Tsuji, T., Matsuzaki, J., Kelly, M. P., Ramakrishna, V., Vitale, L., He, L. Z., Keler, T., Odunsi, K., Old, LJ., Ritter, G., and Gnjatic. S. (2010) Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8-and CD4-T cell responses with broad antigen specificity. J. Immunol. 186, 1218-1227
36. Liu, Y., Gao, X., Masuda, E., Redecha, P. B., Blank, M. C., and Pricop, L. (2006) Regulated expression of FcgammaR in human dendritric cells controls cross-presentation of antigen-antibody complexes. J. Immunol. 177, 8440-8447
37. Regnault, A., Lankar., D., Lacabanne, V., Rodriguez, A., Théry, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., and Amigorena, S. (1999) Fcgamma receptormediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189, 371-380
38. Leiriao, P., del Fresno, C., and Ardavìn, C. (2012) Monocytes as effector cells: activated Ly-6Chigh mouse monocytes migrate to the lymph nodes through the lymph and cross-present antigens to CD8-T cells. Eur. J. Immunol. 42, 2042-2051
39. Kato, M., McDonald, K. J., Khan, S., Ross, I. L., Vuckovic, S., Chen, K., Munster, D., MacDonald, K. P., and Hart, D. N. (2006) Expression of human DEC-205 (CD205) multilectin receptor on leukocytes. Int Immunol 18, 857-869
40. Meyers, J. D., Flournoy, N., and Thomas, E. D. (1986) Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect. Dis. 153, 478-488
41. Patel, N., Snyder, L. D., Finlen-Copeland, A., and Palmer, S. M (2012). Is prevention the best treatment? CMV after lung transplantation. Am J. Transplant. 12, 539-544
42. Yao, J., Bechter, C., Wiesneth, M., Harter, G., Gotz, M., and Germeroth, L. (2008) Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study. Clin. Infect. Dis. 46, 96-105
43. Sant, A. J., and McMichael, A. (2012) Revealing the role of CD4(+) T cells in viral immunity. J. Exp. Med. 209, 1391-1395
44. Goffinet, C., and Keppler, O. T. (2006) Efficient nonviral gene delivery into primary lymphocytes from rats and mice. FASEB J. 20, 500-502